Lung cancer

The risk of post-operative pulmonary complications in lung resection candidates with normal forced expiratory volume in 1 s and diffusing capacity of the lung for carbon monoxide: a prospective multicentre study
Ivan Cundrle, Zdenek Merta, Monika Bratova, Pavel Homolka, Ladislav Mitas, Vladimir Sramek, Michal Svoboda, Zdenek Chovanec, Milos Chobola, Lyle J. Olson, Kristian Brat

ERJ Open Research Mar 2023, 9 (2) 00421-2022; DOI: 10.1183/23120541.00421-2022
Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
Manuela Funke-Chambour, Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Athol U. Wells, Jacques Cadranel

ERJ Open Research Oct 2022, 8 (4) 00469-2022; DOI: 10.1183/23120541.00469-2022
Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
Yuriko Ishida, Satoshi Ikeda, Akimasa Sekine, Tomohisa Baba, Takashi Ogura

ERJ Open Research Oct 2022, 8 (4) 00337-2022; DOI: 10.1183/23120541.00337-2022
1-year mortality in lung cancer in France according to key timepoints of care pathways
Axelle Rivière, Anne Isabelle Lecuyer, Emeline Laurent, Carole Lefebvre, Thierry Lecomte, Elodie Olivier, Delphine Carmier, Laurent Plantier, Leslie Grammatico-Guillon

ERJ Open Research Oct 2022, 8 (4) 00157-2022; DOI: 10.1183/23120541.00157-2022
Pathological characteristics of mediastinal masses in Sri Lanka 2017–2021: a retrospective observational study
Yasith Mathangasinghe, Saman Pradeep, Udeshika Perera, Ramani Punchihewa

ERJ Open Research Oct 2022, 8 (4) 00256-2022; DOI: 10.1183/23120541.00256-2022
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer
Rolof G.P. Gijtenbeek, Vincent van der Noort, Joachim G.J.V. Aerts, Jeske A. Staal-van den Brekel, Egbert F. Smit, Frans H. Krouwels, Frank A. Wilschut, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Joost D.J. Janssen, Martijn Goosens, Paul M. van den Berg, A. Joop de Langen, Jos A. Stigt, Ben E.E.M. van den Borne, Harry J.M. Groen, Wouter H. van Geffen, Anthonie J. van der Wekken

ERJ Open Research Oct 2022, 8 (4) 00239-2022; DOI: 10.1183/23120541.00239-2022
Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors
Emily Pei-Ying Lin, Li-Ching Huang, Jennifer Whisenant, Sally York, Travis Osterman, Jennifer Lewis, Wade Iams, Emily Skotte, Amanda Cass, Chih-Yuan Hsu, Yu Shyr, Leora Horn

ERJ Open Research Oct 2022, 8 (4) 00684-2021; DOI: 10.1183/23120541.00684-2021
Gene expression profile of epithelial–mesenchymal transition in tumours of patients with nonsmall cell lung cancer: the influence of COPD
Yingchen Xia, Jianhua Zha, Víctor Curull, Albert Sánchez-Font, Maria Guitart, Alberto Rodríguez-Fuster, Rafael Aguiló, Esther Barreiro

ERJ Open Research Jul 2022, 8 (3) 00105-2022; DOI: 10.1183/23120541.00105-2022
Computed tomography on lung cancer screening is useful for adjuvant comorbidity diagnosis in developing countries
Juliane Nascimento de Mattos, Carlos Eugênio Santiago Escovar, Manuela Zereu, Adalberto Sperb Rubin, Spencer Marcantonio Camargo, Tan-Lucien Mohammed, Ricardo Sales dos Santos, Nupur Verma, Diana Penha Pereira, Erique Guedes Pinto, Tiago Machuca, Tássia Machado Medeiros, Bruno Hochhegger

ERJ Open Research Apr 2022, 8 (2) 00061-2022; DOI: 10.1183/23120541.00061-2022
Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges
Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells, Manuela Funke-Chambour

ERJ Open Research Apr 2022, 8 (2) 00115-2022; DOI: 10.1183/23120541.00115-2022

Main menu

User menu

Search

Lung cancer

Pages

Contact us